Ischemia and No Obstructive Coronary Artery Disease
Thomas J. Ford(Golden Jubilee National Hospital), Colin Berry(University of Glasgow), Novalia Sidik(University Hospitals Bristol NHS Foundation Trust), Rhian M. Touyz(University of Ottawa), Keith Robertson(Golden Jubilee National Hospital), Robert McDade(Golden Jubilee National Hospital), Eric Yii(University of Glasgow), Margaret McEntegart(Golden Jubilee National Hospital), Stuart Watkins(Golden Jubilee National Hospital), Hany Eteiba(Golden Jubilee National Hospital), Keith G. Oldroyd(Golden Jubilee National Hospital), Damien Collison(Golden Jubilee National Hospital), Christopher Rush(University of Glasgow), Mitchell Lindsay(Golden Jubilee National Hospital), Stuart Hood(Golden Jubilee National Hospital), Alex McConnachie(University of Glasgow), Naveed Sattar(University of Glasgow), Peter McCartney(University of Glasgow), Aadil Shaukat(Golden Jubilee National Hospital), David Corcoran(University of Glasgow), Ross McGeoch(Hairmyres Hospital), Bethany Stanley(University of Glasgow), Paul Rocchiccioli(Golden Jubilee National Hospital), Richard Good(Golden Jubilee National Hospital)
Cited by 176
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
|The Lancet Diabetes & Endocrinology|2019|1.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k